Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / IBRX - ImmunityBio: Buy Low Now Vs. Buy High Later


IBRX - ImmunityBio: Buy Low Now Vs. Buy High Later

2024-02-11 02:41:56 ET

Summary

  • Pre-PDUFA positioning is a good opportunity to buy ImmunityBio stock at a low price.
  • Multiple catalysts could drive the stock price higher over the next 24 months.
  • ImmunityBio has the potential to become a big pharma company rather than being sold.

Editor's note: Seeking Alpha is proud to welcome Ben Rogers as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to SA Premium. Click here to find out more » ...

For further details see:

ImmunityBio: Buy Low Now Vs. Buy High Later
Stock Information

Company Name: ImmunityBio Inc.
Stock Symbol: IBRX
Market: NASDAQ
Website: immunitybio.com

Menu

IBRX IBRX Quote IBRX Short IBRX News IBRX Articles IBRX Message Board
Get IBRX Alerts

News, Short Squeeze, Breakout and More Instantly...